<DOC>
	<DOCNO>NCT01628432</DOCNO>
	<brief_summary>The study compare effect bilateral salpingectomy associate conservative hysterectomy ovarian function standard hysterectomy conservation ovary tube term hormone assay , ovarian ultrasound evaluation , complication , quality life .</brief_summary>
	<brief_title>Effect Salpingectomy During Conservative Hysterectomy</brief_title>
	<detailed_description>Hysterectomy one common gynecologic procedure perform clinical practice . In study focus non menopausal patient 52 year hysterectomies benign disease : uterine leiomyoma , adenomyosis , endometriosis , dysfunctional uterine bleeding , genital prolapse , cervical dysplasia ... failure conservative treatment . standard procedure hysterectomy conservation ovary preservation fallopian tube clamp place close uterine corpus possible . suggested decrease interference vascular structure mesosalpinx mesovarium . however unclear whether tubal conservation time hysterectomy influence ovarian blood flow ovarian reserve . another point consider occurrence post-hysterectomy carcinoma preserve fallopian tube , theoretically , case could prevent tubal excision perform hysterectomy The study compare effect bilateral salpingectomy associate conservative hysterectomy ovarian function standard hysterectomy conservation ovary tube term hormone assay , ovarian ultrasound evaluation , complication , quality life . impact treatment ovarian reserve test measure AMH baseline 3 day , 6 week 6 , 12 month surgery . quality life also assess time point , questionnaire ( Women Health Questionnaire WHQ ) .</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Adenomyosis</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Uterine Prolapse</mesh_term>
	<mesh_term>Genital Diseases , Female</mesh_term>
	<criteria>age â‰¥ 18 year less 52 year indication conservative hysterectomy benign disease sign informed consent non menopausal woman ( AMH &gt; 0,21 ng/ml ) pregnancy desire future pregnancy menopausal status patient unable give inform consent physical psychiatric condition could impair patient 's ability cooperate post operative data collection previous salpingo /or oophorectomy ( unilateral bilateral ) genital cancer disease atypical endometrial hyperplasia hyperandrogenia ovarian mass need surgical exploration immunotherapy could interfere immunological test</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>52 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>